NCI Cancer Bulletin: A Trusted Source for Cancer Research News
NCI Cancer Bulletin: A Trusted Source for Cancer Research News
August 7, 2007 • Volume 4 / Number 23 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.

Notes

Ray Named Deputy Director for Management
Lawrence Ray was recently named NCI's new Deputy Director for Management and Executive Officer. In this role, Ray will serve as the chief operating officer of the Institute and will oversee administrative management of NCI's programs. He will have key responsibilities in execution of the budget and work force management.

Ray spent 26 years in federal service, principally at NIH. Fourteen of those years were with NCI as chief administrative officer of the Division of Extramural Activities, coordinator of patent licensing and collaborative research and development agreements for the Institute, chief administrative officer of the Division of Cancer Treatment, and deputy associate NCI director, responsible for all aspects of administrative management. From 2003 until just recently, he served as vice president for research operations at Beth Israel Deaconess Medical Center. Before that, he was vice president of clinical program development at Dana-Farber/Partners CancerCare and program administrator for clinical sciences at Dana-Farber/Harvard Cancer Center.

Ray received his B.A. and M.A. from the University of Kentucky. He also holds a law degree from Catholic University and is a member of the Pennsylvania and District of Columbia bars.

 

Steeg Named a Deputy Editor of Clinical Cancer Research
Dr. Patricia Steeg, of NCI's Center for Cancer Research (CCR), has been named a deputy editor of the journal Clinical Cancer Research. Dr. Steeg is head of the Women's Cancers Section in the Laboratory of Molecular Pharmacology and director of CCR's Molecular Therapeutics Program.

Clinical Cancer Research focuses on innovative clinical research and translational research that bridges the laboratory and the clinic. The journal publishes original articles on clinical trials evaluating new treatments for cancer; research on molecular abnormalities that predict incidence, response to therapy, and outcome; and laboratory studies of new drugs and biological agents that will lead to clinical trials in patients.

Dr. Steeg assumes her new editorial position in September 2007. She will join Dr. Ken Anderson from Harvard University, who will be the journal's new editor-in-chief.

 

All-Ireland NCI Cancer Consortium Web Site Wins Award
Interactive Media Awards 2007 logo NCI has received an Outstanding Achievement award from Interactive Media Awards for excellence in the design, development, and implementation of the All-Ireland NCI Cancer Consortium Web site. Creation of this Web site was a collaborative effort by NCI's Office of International Affairs and Office of Communications and Education.

The award recognizes that the project met and surpassed standards of excellence that comprise the Web's most professional work. The judges evaluated design, usability, innovation in technical features, standards compliance, and content. To win this award, the site had to meet strict guidelines in each area, a standard achieved by only a fraction of sites in the competition each year.